Queen City Angels-backed Alphyn eyes another fundraise amid ‘positive’ clinical study results
January 11, 2023 at 06:37 AM EST
Alphyn Biologics, a clinical-stage dermatology company developing a new class of drugs for skin diseases, will pursue a Series B financing round in 2023.
